Health Tech
AI and Multi-Omics Converge: Cardio Diagnostics Targets Earlier, More Precise Cardiac Insights
Cardio Diagnostics Holdings is leveraging artificial intelligence and multi-omic biomarkers to improve early detection and personalized treatment of cardiovascular disease, addressing a critical gap in traditional risk assessment.
Aclarion Expands Commercial Team Amid Triple-Digit Growth in Nociscan Utilization
Aclarion granted inducement stock options to its new Western U.S. Commercial Director as demand for its Nociscan platform surges, reflecting strong adoption of its AI-driven chronic low back pain diagnostic tool.
HeartBeam Targets Heart Disease with Advanced ECG Technology as Cardiovascular Deaths Surge
HeartBeam Inc. is developing next-generation ECG solutions to address the gap in early cardiac detection, as cardiovascular disease remains the leading cause of death in the U.S. with over 919,000 deaths in 2023.
Cardio Diagnostics Harnesses AI and Biomarkers to Combat Heart Disease Burden
Cardio Diagnostics Holdings is advancing early detection of cardiovascular disease using an AI-powered platform that analyzes epigenetic and genetic biomarkers from a simple blood sample, addressing the leading cause of death in the U.S.
Cardio Diagnostics Leverages AI and Biomarkers to Combat Cardiovascular Disease
Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) is advancing early detection of heart disease using a platform that combines artificial intelligence with multi-omic biomarker analysis, addressing the urgent need for innovation in cardiovascular care.
ResQ Launches Fall Detection Series and Mahi Collection, Blending Safety with Style
ResQ introduces automatic fall detection and a new jewelry-inspired line, enhancing personal safety wearables with design and technology.
Cardio Diagnostics Targets Precision Cardiology with Multi-Omic AI Platform
Cardio Diagnostics Holdings (NASDAQ: CDIO) leverages AI to integrate epigenetic and genetic biomarkers for personalized cardiovascular risk assessments, potentially transforming disease prevention and treatment.
HeartBeam to Report Q1 Earnings, Update on Commercial Launch and AI Initiatives
HeartBeam Inc. will host a Q1 2026 earnings call to discuss financial results and provide updates on its limited commercial launch for arrhythmia assessment, extended-wear patch development, and AI programs, marking a pivotal moment for the company's cardiac care innovations.
Ventripoint's AI-Powered Cardiac Imaging System Submitted for Expedited Approval in China
Ventripoint Diagnostics announced that its VMS+ 4.0 system has been submitted for regulatory approval in China via an expedited 'green channel' pathway, potentially accelerating access to AI-driven cardiac diagnostics in a market with 330 million cardiovascular patients.
Cardio Diagnostics Leverages AI and Multi-Omic Biomarkers to Combat Cardiovascular Disease
Cardio Diagnostics Holdings is advancing AI-driven blood tests for earlier, more personalized detection and management of cardiovascular disease, addressing the leading cause of death in the U.S.
Cardio Diagnostics Leverages AI and Genomics to Revolutionize Cardiovascular Disease Detection
Cardio Diagnostics Holdings (NASDAQ: CDIO) is advancing AI-powered solutions using simple blood tests to detect and manage cardiovascular disease, addressing the leading cause of death in the US.
Catalyst Crew Technologies CEO to Attend HLTH Europe 2026, Seeking Strategic Growth in Digital Health
Catalyst Crew Technologies Corp. announced its CEO will attend HLTH Europe 2026 to explore partnerships and market trends, supporting its expansion in AI-driven telehealth for emerging markets.
Cardio Diagnostics' AI Platform Aims to Transform Cardiovascular Risk Assessment
Cardio Diagnostics Holdings uses artificial intelligence and multi-omic data from a simple blood draw to provide personalized cardiovascular risk assessments, potentially shifting heart health diagnostics from population-based models to precise, individualized insights.
HeartBeam Partners with Mount Sinai to Develop AI-Driven ECG Algorithms
HeartBeam's collaboration with Mount Sinai aims to advance AI-enabled ECG analysis, reinforcing its role in the shift toward data-driven remote cardiac monitoring.
FastBlast Launches Interactive Quiz to Simplify Intermittent Fasting and Personalize Plans
FastBlast introduces an interactive quiz that helps individuals find a personalized intermittent fasting approach based on their habits and preferences, aiming to remove guesswork and support consistency.
HeartBeam Announces Public Offering to Fund Cardiac Technology Commercialization and AI Development
HeartBeam Inc. is launching a public offering to finance the commercialization of its FDA-cleared 12-lead ECG system and advance AI initiatives for cardiac care.
Polyrizon Secures $3.5 Million in Funding to Advance Intranasal Protective Technology
Polyrizon Ltd. has raised $3.5 million through a registered direct offering and private placement to fund development of its nasal spray hydrogel technology designed to create protective barriers against viruses and allergens.
Catalyst Crew Technologies Launches Telehealth Platform Targeting Latin American Healthcare Gaps
Catalyst Crew Technologies has launched its telehealth platform in Venezuela, aiming to address infrastructure constraints and fragmented care delivery across Latin America through AI-driven healthcare coordination.
Catalyst Crew Technologies Advances Telehealth Platform Development for Latin American Markets
Catalyst Crew Technologies is developing an AI-integrated telehealth platform focused on emerging markets, starting with Venezuela, to improve healthcare coordination and data-driven insights in regions with growing demand for modernized medical services.
New AI Tool Shows Promise for Early Lung Cancer Detection
A new artificial intelligence tool could significantly improve early detection of lung cancer, potentially increasing survival rates for a disease that remains the leading cause of cancer-related deaths worldwide.
10X Health Appoints Will Sliger as CMO to Drive Brand and Marketing for Precision Health Platform
10X Health names Will Sliger as Chief Marketing Officer to build the marketing engine behind its personalized health and performance platform, signaling a strategic push to scale its brand and go-to-market operations.
HeartBeam Closes $10 Million Public Offering to Accelerate Cardiac Tech Commercialization
HeartBeam Inc. raised $10 million in a public offering to fund the commercialization of its FDA-cleared 12-lead synthesized ECG system and other cardiac technologies.
Cardio Diagnostics Holdings Gains Attention for AI-Driven Cardiovascular Platform
Cardio Diagnostics Holdings is highlighted as a company to watch due to its AI-powered approach to cardiovascular disease prevention, detection, and management, integrating epigenetics and genetics for personalized insights.
Gallup Survey Reveals Growing Use of AI to Supplement Healthcare Visits
A Gallup and West Health survey found that many Americans are using AI tools to complement their healthcare interactions, with usage patterns varying by age, income, and motivation, highlighting implications for providers and policymakers.
HeartBeam Closes $10M Public Offering to Fund Commercialization of ECG Technology
HeartBeam raised $10 million in a public offering to advance its FDA-cleared 12-lead synthesized ECG system and heart attack detection technologies, positioning the company for expanded market reach.
BRYGE AI Wins Silver Stevie Award for Women-Focused Health Technology Innovation
BRYGE AI's recognition at the 2025 Stevie Awards for Women in Business highlights the growing importance of technology solutions addressing communication challenges faced by women with ADHD in professional and personal settings.
HeartBeam Ranked Second Globally in Portable ECG Innovation
HeartBeam has been recognized as a top global innovator in portable ECG technology, ranking second worldwide in 12-lead ECG innovation among 243 companies analyzed, highlighting the company's growing influence in remote cardiac care solutions.
Biohacking Index Report Identifies Top 10 Wellness Brands Driving Verified Innovation
The October 2025 Biohacking Index Report reveals ten high-growth wellness brands leading the industry through data-backed transparency and verified consumer reviews, highlighting a shift toward evidence-based health solutions.
HeartBeam Partners with HeartNexus to Expand Remote Cardiac Diagnostic Access
HeartBeam's collaboration with HeartNexus enables 24/7 cardiologist access for remote ECG interpretation, addressing critical gaps in cardiovascular care accessibility worldwide.
Biohacking Index Report Identifies Top 10 Verified Wellness Brands Driving Industry Transparency
The October 2025 Biohacking Index Report reveals the leading wellness brands that are transforming consumer trust through verified reviews and data-backed validation, highlighting a shift toward evidence-based health decisions in the rapidly growing biohacking market.